
Gufic Biosciences Limited Re-appoints Mr. Pankaj Jayakumar Gandhi as Whole Time Director for Five Years
Gufic Biosciences Limited has confirmed the re-appointment of Mr. Pankaj Jayakumar Gandhi as a Whole Time Director of the company. The decision was reached following the Board of Directors meeting held on July 31, 2026.The re-appointment covers a further term of five years for Mr. Gandhi. His tenure is effective from September 07, 2026, and extends until September 06, 2031 (both days inclusive). The appointment is subject to the approval of shareholders at the ensuing 42nd Annual General Meeting of Gufic Biosciences Limited.
Mr. Pankaj Jayakumar Gandhi has been confirmed as not being debarred from holding the office of Director by any order passed by Securities and Exchange Board of India or any other relevant authority.
Director Profile Details
Mr. Pankaj Gandhi possesses a Bachelor's degree in Commerce from the University of Mumbai. He brings over three decades of extensive experience, particularly in liaising with regulatory authorities within the pharmaceutical industry. His expertise has been instrumental in ensuring operational efficiency and compliance with various statutory and regulatory bodies for the company. Furthermore, the Board confirmed that Mr. Pankaj Gandhi is not related to any other Directors of Gufic Biosciences Limited.The key details regarding this re-appointment are summarized below:
| Particular | Detail |
|---|---|
| Director | Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) |
| Role | Whole Time Director |
| Effective Date | September 07, 2026 |
| Term Length | Five years |
| Tenure End Date | September 06, 2031 |
This appointment secures the role of Mr. Gandhi within Gufic Biosciences Limited, supporting the company's operations in the pharmaceutical sector.
GUFICBIO Stock Price Movement
Today, Gufic Biosciences Limited shares edged higher to close at ₹389.85, marking a 1.84% gain in the post-market session. The equity traded 38,177 shares during the day, maintaining strong buying interest as it closed near its high of ₹391.95.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.